Buchumschlag

Myokines are associated with progression, course and mortality in alcohol‐associated liver disease

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Parminder Kaur, Nipun Verma, Pratibha Garg, Samonee Ralmilay, Aishani Wadhawan, Rohit Nadda, Jiya Prajapati, Gaurav Sharma, Sahaj Rathi, Arka De, Madhumita Premkumar, Sunil Taneja, Ashwani K. Singal, Ajay Duseja
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Identification of four novel acute‐on‐chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods
von: Nipun Verma, et al.
Veröffentlicht: (2024)

Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study
von: Nipun Verma, et al.
Veröffentlicht: (2026)

Review article: Evaluation and care of the critically ill patient with cirrhosis
von: Iva Kosuta, et al.
Veröffentlicht: (2024)

Letter: Myokines Are Also Associated With Disease Course in Primary Biliary Cholangitis
von: Leyu Zhou, et al.
Veröffentlicht: (2024)

Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study
von: Nipun Verma, et al.
Veröffentlicht: (2024)

Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance. Authors' Reply
von: Rohit Mehtani, et al.
Veröffentlicht: (2026)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
von: Mushfiqur R. Siddique, et al.
Veröffentlicht: (2025)

Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
von: Pojsakorn Danpanichkul, et al.
Veröffentlicht: (2024)

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma
von: Ashwini Arvind, et al.
Veröffentlicht: (2025)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy
von: Mustafa Mohamedrashed, et al.
Veröffentlicht: (2024)

Very Early‐Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma
von: Thomas Hunold, et al.
Veröffentlicht: (2025)

Letter: Reflections on the significance of myokines in alcohol‐associated liver disease
von: Yaomin Wang, et al.
Veröffentlicht: (2024)

Letter: Addressing opioid exposure and associated harms in patients with IBD
von: Christian P. Selinger, et al.
Veröffentlicht: (2024)

Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
von: Pojsakorn Danpanichkul, et al.
Veröffentlicht: (2024)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy—Authors' reply
von: Annalisa Schiepatti, et al.
Veröffentlicht: (2024)

Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD
von: Maria Ling Lundström, et al.
Veröffentlicht: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
von: Amanda Ricciuto, et al.
Veröffentlicht: (2024)

Editorial: Solving the acute kidney injury puzzle in alcohol‐associated hepatitis—Challenges and insights
von: Vishnu Girish, et al.
Veröffentlicht: (2024)

Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States
von: Donghee Kim, et al.
Veröffentlicht: (2024)

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
von: Nathan Grellier, et al.
Veröffentlicht: (2024)

Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
von: Marcus M. Mücke, et al.
Veröffentlicht: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
von: D. Bogatic, et al.
Veröffentlicht: (2024)

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
von: Nabil Noureddin, et al.
Veröffentlicht: (2024)

Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
von: Carolin V. Schneider, et al.
Veröffentlicht: (2024)

The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis
von: María Hernández‐Pérez, et al.
Veröffentlicht: (2024)

Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease
von: Richie Manikat, et al.
Veröffentlicht: (2024)

Paediatric‐onset immune‐mediated inflammatory disease is associated with an increased mortality risk—A nationwide study
von: Mikkel Malham, et al.
Veröffentlicht: (2024)

Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium
von: Ann T. Ma, et al.
Veröffentlicht: (2024)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
von: Ayesha Shah, et al.
Veröffentlicht: (2024)

Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
von: Mohamad Jamalinia, et al.
Veröffentlicht: (2024)

Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply
von: Sagnik Biswas, et al.
Veröffentlicht: (2024)

Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study
von: Rahul Kumar, et al.
Veröffentlicht: (2024)

Editorial: DoesESWL‐ERCPfor pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis?
von: Richard Kozarek
Veröffentlicht: (2024)

Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Addressing key methodological and regional challenges
von: Rui Zhang, et al.
Veröffentlicht: (2024)

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
von: Nobuharu Tamaki, et al.
Veröffentlicht: (2024)

Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey
von: Rocio Enriquez, et al.
Veröffentlicht: (2024)

Editorial: DoesESWL‐ERCPfor pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis? Authors' reply
von: Yu Liu, et al.
Veröffentlicht: (2024)

Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study
von: Angelo Armandi, et al.
Veröffentlicht: (2024)

Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
von: Yewan Park, et al.
Veröffentlicht: (2024)

Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints
von: Philippe Sultanik, et al.
Veröffentlicht: (2024)